Search

CIRM grant will help expand patients’ access to UCLA clinical trials for stem cell, gene therapies

A five-year, $8 million grant from the California Institute for Regenerative Medicine will enable UCLA stem cell scientists to include a wider cross-s...

For older breast cancer survivors, cognitive problems may be linked to inflammation, study shows

Scientists are still trying to understand why many breast cancer survivors experience troubling cognitive problems for years after treatment....

UCLA post-doctoral scholar receives award to search for genetic clues to predict prostate cancer aggressiveness

Roni Haas, PhD, postdoctoral scholar in the lab of Paul Boutros has received the 2022 Todd Boehly-PCF Young Investigator Award from the Prostate Cance...

UCLA researchers identify model for studying treatments targeting MS progression

A new study from UCLA researchers identified an animal model that could be used to study treatments for improving disabilities in multiple sclerosis p...

Telehealth follow-up associated with increased returns and hospitalizations after emergency department visit

Telehealth follow-up consultations following an emergency department visit were associated with 28 more repeat ED encounters and nearly 11 more return...

Study shows inexpensive, readily available chemical may limit impact of COVID-19

Preclinical studies in mice that model human COVID-19 suggest that an inexpensive, readily available amino acid might limit the effects of the disease...

How does racism make you sick?

“Right now, there's lots of calls for racism to be viewed as a public health crisis,” says Gilbert Gee, PhD, a professor in the Department of Comm...

Space medicine: Future interplanetary travel will depend on it

Antigen testing for COVID can be a useful tool for healthcare systems’ return-to-work guidance

The findings demonstrate how the rapid antigen test can be used to triage healthcare workers for returning to work during periods of acute staffing sh...

UCLA researchers identify a gene as a potential target in treatment-resistant brain cancer glioblastoma multiforme

Research led by doctors and scientists at UCLA Jonsson Comprehensive Cancer Center and the UCLA Jane & Terry Semel Institute for Neuroscience & Human ...